Key result
Molecular docking and QSAR models revealed that the secondary amine group of CW-33 forms hydrogen bonds with Glu155, and its phenyl and ethyl moieties interact with Arg76 and Glu74 of the JEV protease.
Molecular docking and QSAR modeling reveal the structural characteristics required for the binding of CW-33 to the JEV protease, aiding potential drug development.
No takes yet. Share an insight, caveat, or question.
Supports CW-33 as JEV protease inhibitor lead; leaves open antiviral efficacy pending experimental validation.
Chen et al. (2019) studied Japanese encephalitis virus (JEV). CW-33 and its analogues was evaluated on Molecular docking simulation and QSAR models for antiviral activities. Molecular docking and QSAR models revealed that the secondary amine group of CW-33 forms hydrogen bonds with Glu155, and its phenyl and ethyl moieties interact with Arg76 and Glu74 of the JEV protease.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: